Coronary No-Reflow Phenomenon in Clinical Practice

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Biology

Background:

• Coronary revascularization aims to restore blood flow but can result in coronary no-reflow, impeding myocardial reperfusion.
• Coronary no-reflow is linked to adverse clinical events and poorer patient prognosis.
• The precise pathophysiology of no-reflow remains incompletely understood.

Purpose of the Study:

• To review the current understanding of coronary no-reflow pathophysiology.
• To identify factors associated with no-reflow.
• To discuss current and potential management strategies.

Main Methods:

• Literature review of studies on coronary no-reflow.
• Analysis of proposed pathophysiological mechanisms.
• Summary of clinical associations and management approaches.

Main Results:

• Proposed mechanisms include distal embolization, ischemic injury, endothelial dysfunction, and microvascular susceptibility.
• Associated factors include older age, diabetes, hypercholesterolemia, prolonged ischemia, hemodynamic instability, high thrombus burden, complex lesions, and multivessel disease.
• Non-pharmacological interventions like embolic protection devices and thrombus aspiration have not improved outcomes.

Conclusions:

• Effective prevention and management strategies for coronary no-reflow are lacking.
• Intracoronary vasodilators (adenosine, verapamil, nitroprusside) and reduced reperfusion times are current preventive measures.
• Further research into no-reflow pathophysiology is crucial for developing targeted therapies.